Drug Type Fab fragment, Antitoxin |
Synonyms Immunoglobulin F(ab’)2 fragments of equine origin (MicroPharm) |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date FR (30 Oct 2020), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Crotaline Snake Venom | FR | 30 Oct 2020 |